University of Oxford | United Kingdom
Adrian Hill is a leader in the design and development of vaccines for globally important infectious diseases. He showed that simian adenovirus vectors can safely induce potent cellular and humoral immunity against malaria and Ebola, and recent application of this technology to COVID-19 led to widespread vaccine licensure and deployment. His team's virus-like-particle-based malaria vaccine is in phase III trials.
Keywords: Vaccines / SARS-Cov-2 / adenoviral vectors / Plasmodium falciparum malaria / Ebola / therapeutic vaccines / T cell-inducing vaccines / virus-like particles